These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1902592)

  • 1. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome.
    Kara CJ; Glimcher LH
    Science; 1991 May; 252(5006):709-12. PubMed ID: 1902592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome).
    Steimle V; Durand B; Barras E; Zufferey M; Hadam MR; Mach B; Reith W
    Genes Dev; 1995 May; 9(9):1021-32. PubMed ID: 7744245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A regulatory element in the beta 2-microglobulin promoter identified by in vivo footprinting.
    Lonergan M; Dey A; Becker KG; Drew PD; Ozato K
    Mol Cell Biol; 1993 Nov; 13(11):6629-39. PubMed ID: 8413259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome).
    Steimle V; Otten LA; Zufferey M; Mach B
    Cell; 1993 Oct; 75(1):135-46. PubMed ID: 8402893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequences and factors: a guide to MHC class-II transcription.
    Glimcher LH; Kara CJ
    Annu Rev Immunol; 1992; 10():13-49. PubMed ID: 1590984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental and cytokine-mediated regulation of MHC class II gene promoter occupancy in vivo.
    Kara CJ; Glimcher LH
    J Immunol; 1993 Jun; 150(11):4934-42. PubMed ID: 8496595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter accessibility within the environment of the MHC is affected in class II-deficient combined immunodeficiency.
    Kara CJ; Glimcher LH
    EMBO J; 1993 Jan; 12(1):187-93. PubMed ID: 8428578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
    Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
    J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occupancy of upstream regulatory sites in vivo coincides with major histocompatibility complex class I gene expression in mouse tissues.
    Dey A; Thornton AM; Lonergan M; Weissman SM; Chamberlain JW; Ozato K
    Mol Cell Biol; 1992 Aug; 12(8):3590-9. PubMed ID: 1630463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of MHC class II transcription in two type III bare lymphocyte syndrome patients of a single family.
    Lambert M; Van Eggermond M; Verheij C; Van Ree J; Van den Elsen P
    Immunodeficiency; 1993; 4(1-4):277-84. PubMed ID: 8167718
    [No Abstract]   [Full Text] [Related]  

  • 13. CIITA-induced occupation of MHC class II promoters is independent of the cooperative stabilization of the promoter-bound multi-protein complexes.
    Villard J; Muhlethaler-Mottet A; Bontron S; Mach B; Reith W
    Int Immunol; 1999 Mar; 11(3):461-9. PubMed ID: 10221658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator.
    Rigaud G; Paiola F; Accolla RS
    Eur J Immunol; 1994 Oct; 24(10):2415-20. PubMed ID: 7925569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes.
    Doyle C; Ford PJ; Ponath PD; Spies T; Strominger JL
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4590-4. PubMed ID: 2112745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperativity between the J and S elements of class II major histocompatibility complex genes as enhancers in normal and class II-negative patient and mutant B cell lines.
    Sugawara M; Scholl T; Mahanta SK; Ponath PD; Strominger JL
    J Exp Med; 1995 Jul; 182(1):175-84. PubMed ID: 7790817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-consensus DNA sequences function in a cell-type-specific enhancer of the mouse class II MHC gene A alpha.
    Whitley MZ; Sisk R; Ivashkiv LB; Finn PW; Glimcher LH; Boothby MR
    Int Immunol; 1991 Sep; 3(9):877-88. PubMed ID: 1931814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency.
    Durand B; Sperisen P; Emery P; Barras E; Zufferey M; Mach B; Reith W
    EMBO J; 1997 Mar; 16(5):1045-55. PubMed ID: 9118943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y.
    Reith W; Siegrist CA; Durand B; Barras E; Mach B
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):554-8. PubMed ID: 8290561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5.
    Scholl T; Mahanta SK; Strominger JL
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6330-4. PubMed ID: 9177217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.